Target intelligence / Profile preview

Tetanus Toxoid Helper Peptide

Molecular classification: Peptide, T-cell epitope, Vaccine adjuvant

Overview

The tetanus toxoid helper peptide is a synthetic peptide derived from the tetanus toxin. It functions as a universal T-helper cell epitope, capable of binding to multiple MHC class II alleles and activating CD4+ T-cells. It is used in vaccine development and immunological research to enhance immune responses to weakly immunogenic antigens.

Other names: QYIKANSKFIGITELAQYIKANSKFIGITELTET 830Tetanus toxin T cell epitope

Mechanism of action

Enhances antigen presentation to T-helper cells, promoting a robust and long-lasting immune response.

Biological functions

MHC class II bindingT-helper cell activationImmune response enhancementVaccine adjuvant activity

Disease associations

Infectious disease (vaccine target)Cancer (vaccine target)

Beyond the preview

Go deeper on Tetanus Toxoid Helper Peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetanus Toxoid Helper Peptide.

Explore the full profile